KRCA-0008
| CAS No. | 1472795-20-2 | Cat. No. | BCP16229 |
| Name | KRCA-0008 | ||
| Synonyms | KRCA0008;KRCA 0008; | ||
| Formula | C30H37ClN8O4 | M. Wt | 609.12 |
| Description | KRCA-0008 is a potent and selective ALK/Ack1 inhibitor with IC50 of 12 nM/4 nM for ALK and Ack1 respectively; displays drug-like properties without hERG liability.KRCA-0008 is a potent dual inhibitor of Ack1 and anaplastic lymphoma kinase (ALK). | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | ALK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.